Advances in Multiple Myeloma treatment Offer Hope for Longer Survival

The recent Netflix drama, though ⁢fictional, touched‍ on the realities of multiple myeloma, a blood cancer. The character Kwan-suk’s death highlighted the disease’s severity, but ⁣medical advancements offer a more optimistic outlook for patients diagnosed today.

Understanding Multiple Myeloma

Multiple myeloma is a type of blood cancer affecting plasma cells, which are responsible for producing antibodies. In myeloma, these cells become cancerous and produce abnormal⁣ antibodies known as M proteins. These M proteins don’t function properly and can lead to various health complications.

Dr. Lee ⁢Jae-hoon, a professor of hematology at ⁤Gachon University Gil Hospital, notes that if kwan-suk were diagnosed in 2025, his prognosis would likely be significantly improved due to advancements in treatment.

Multiple myeloma ⁤is the second most common⁢ blood cancer in South Korea, after lymphoma and leukemia. In 2022,⁣ approximately 2,000 new cases were diagnosed. It’s estimated that around 9,000 people ⁣in South Korea are currently living with the disease, including those undergoing treatment and long-term survivors.

Symptoms and Diagnosis

The exact cause of multiple myeloma remains unknown, making prevention challenging. However, early detection is⁤ crucial for successful treatment. Regular health checkups can identify the presence of M proteins in the blood and urine, ‍possibly indicating the disease in its asymptomatic stage.

If M proteins are detected, further tests, such as bone marrow biopsies and imaging scans like CT or MRI, are⁣ performed to confirm the diagnosis and ⁣assess the extent of the disease.

Symptoms of multiple myeloma can vary but may include fatigue, bone pain (especially in the back), fractures, kidney problems, ⁢and neurological issues like confusion⁣ or nausea due to hypercalcemia. According to Dr. Lee, about 70% of patients initially seek medical attention for⁤ orthopedic problems, such as bone pain or fractures, while around 20% present with kidney dysfunction or anemia.

Treatment and Prognosis

While multiple myeloma is not ⁣always ‍curable,meaningful progress has been made⁢ in treatment ⁣over the past two⁢ decades. the introduction of new therapies has dramatically improved survival rates and quality of life for patients.

In the early 2000s, the average survival period was only about three years. Today, ‍many patients live for more⁢ than 10 years after diagnosis.Even⁤ if a cure isn’t possible, long-term management⁤ and improved quality of life are achievable goals.

Treatment strategies typically involve chemotherapy, hematopoietic stem cell transplantation, and radiation therapy. ⁤Chemotherapy ⁤regimens usually consist⁣ of four to six ‍cycles using various anti-cancer drugs. Hematopoietic stem ⁤cell transplantation involves collecting and storing the patient’s own ‍stem cells, followed by high-dose chemotherapy to eliminate cancer cells, and ⁣then re-infusing the stored stem cells.

while⁤ stem ‍cell ⁣transplantation is generally considered for ⁣patients under 70, it may ⁣be an option for ⁣older individuals depending ⁢on their overall health. Many patients with multiple myeloma ⁣are over 50 and may have underlying conditions‍ such as diabetes, ⁤hypertension, or chronic kidney disease.

Hope for the Future

Despite the increasing incidence of⁣ multiple myeloma due to an aging population, treatment outcomes continue to improve. Dr. Lee emphasizes that South Korea’s treatment standards are comparable to those⁤ in the United States, and numerous ⁤global clinical trials are⁤ underway in the country.

Furthermore, advancements in anti-cancer drugs have significantly reduced side effects, making treatment more tolerable. Patients are encouraged to seek medical advice and explore available treatment options.

Ongoing research into novel therapies, such as bispecific antibodies and CAR-T cell therapy, holds promise⁣ for even more⁣ effective ⁤treatments in the future.